Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPacific Horizon Regulatory News (PHI)

Share Price Information for Pacific Horizon (PHI)

Share Price is delayed by 15 minutes
Get Live Data
1,166.00    -22.00 (-1.85%)
Bid:
1,160.00
Ask:
1,168.00
Spread: 8.00 (0.69%)
Market Cap: £933.81m
PHI Live PriceLast checked at - London Stock Exchange

Intraday Pacific Horizon Share Chart

Annual Overview from QuotedData

20 Mar 2025 08:24

RNS Number : 4790B
Pacific Horizon Investment Tst PLC
20 March 2025
 

Pacific Horizon - Annual Overview from QuotedData

20th March 2025

Inflection point approaching?

With Trump now re-installed as US President, we are starting to see how his much talked about policy agenda is shaping up. He is moving quickly, but higher uncertainty is the new norm. Although, there are signs that his threat of stringent US tariffs on Asian and particularly Chinese imports, which had knocked confidence and financial markets, may not be as bad as was previously feared. However, the markets focus on the reflationary aspects of his policies looks justified. Interest rates may well be higher for longer.

Against this backdrop, the managers of Pacific Horizon (PHI) think that it is easy to overlook Asia's advantages. It sees much to be positive about, noting for one that valuations of Asian equities are incredibly cheap, and, after a decade of outflows, there is little hot money (an influx of funds from short-term investors looking to make a quick profit) left in the region. It thinks that, with China enacting unprecedented stimulus, this dampens one of the key headwinds facing the region and the effects could be dramatic if investor sentiment towards Asia turns positive. PHI managers see an inflection point approaching and have been positioning the portfolio accordingly. Such a move could drive down the discount to net asset value (NAV), which is close to a five-year high.

Full Research:

https://quoteddata.com/research/pacific-horizon-inflection-point-approaching-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Pacific Horizon Investment Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGIGDXDDDDGUG
Date   Source Headline
3rd Jun 202612:21 pmRNSNet Asset Value(s)
2nd Jun 20264:59 pmRNSTransaction in Own Shares
2nd Jun 202611:08 amRNSNet Asset Value(s)
1st Jun 202612:35 pmRNSNet Asset Value(s)
1st Jun 20269:48 amRNSTotal Voting Rights
29th May 20264:47 pmRNSTransaction in Own Shares
29th May 202611:48 amRNSNet Asset Value(s)
28th May 20264:48 pmRNSTransaction in Own Shares
28th May 202612:13 pmRNSNet Asset Value(s)
27th May 20264:51 pmRNSTransaction in Own Shares
27th May 202611:52 amRNSNet Asset Value(s)
26th May 202611:32 amRNSNet Asset Value(s)
26th May 20269:55 amRNSNet Asset Value(s)
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 202612:04 pmRNSNet Asset Value(s)
21st May 202611:59 amRNSNet Asset Value(s)
20th May 202611:24 amRNSNet Asset Value(s)
19th May 20264:45 pmRNSTransaction in Own Shares
19th May 202611:50 amRNSNet Asset Value(s)
18th May 20265:00 pmRNSTransaction in Own Shares
18th May 202611:40 amRNSNet Asset Value(s)
15th May 202611:21 amRNSNet Asset Value(s)
14th May 202612:34 pmRNSNet Asset Value(s)
13th May 202611:54 amRNSNet Asset Value(s)
12th May 20263:59 pmRNSHolding(s) in Company
12th May 202612:28 pmRNSNet Asset Value(s)
11th May 202611:51 amRNSNet Asset Value(s)
8th May 20264:56 pmRNSTransaction in Own Shares
8th May 202611:41 amRNSNet Asset Value(s)
7th May 202611:58 amRNSNet Asset Value(s)
6th May 20264:51 pmRNSTransaction in Own Shares
6th May 202611:50 amRNSNet Asset Value(s)
5th May 202611:46 amRNSNet Asset Value(s)
5th May 20268:36 amRNSNet Asset Value(s)
1st May 20262:05 pmRNSNet Asset Value(s)
1st May 20269:36 amRNSTotal Voting Rights
30th Apr 202611:40 amRNSNet Asset Value(s)
29th Apr 20264:47 pmRNSTransaction in Own Shares
29th Apr 202611:36 amRNSNet Asset Value(s)
28th Apr 20264:43 pmRNSTransaction in Own Shares
28th Apr 202612:26 pmRNSNet Asset Value(s)
27th Apr 20265:00 pmRNSTransaction in Own Shares
27th Apr 202612:21 pmRNSNet Asset Value(s)
24th Apr 202612:43 pmRNSNet Asset Value(s)
23rd Apr 20264:52 pmRNSTransaction in Own Shares
23rd Apr 202612:27 pmRNSNet Asset Value(s)
22nd Apr 20264:45 pmRNSTransaction in Own Shares
22nd Apr 202611:47 amRNSNet Asset Value(s)
21st Apr 20264:48 pmRNSTransaction in Own Shares
21st Apr 20263:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.